Since the beginning of the COVID-19 pandemic, significant health concerns has been identified. We have seen the failure of healthcare facilities to cope with the large influx of infected patients. Many patients were diagnosed with advanced pneumonia, which led to difficult situations.

The COVID-19 virus mainly entered the human body through the respiratory tract, and during the incubation period did not show any symptoms, thereby enabling an infected person to spread it among his contacts.

What can be done to prevent such disastrous consequences? Early diagnosis of the virus could significantly limit its spread.

Our team studied the research results of scientists and developers of express test systems, according to the results of which several interesting facts were pointed out:

1. Patients with infectious diseases of the respiratory system have a changed composition of exhaled gases, which gives the right to assert the possibility of detecting the presence of diseases by exhalation;

2. Devices designed for rapid testing of respiratory tract infections based on expiratory analysis have a high price for devices for individual use, and their disinfection or the use of disposable mouthpieces, when used by a large
number of people, does not guarantee safety.

These facts prompted our team to search for solutions that allow us to develop a cheap version of the biomarker that will signal the patient to undergo a medical examination, without waiting for a deterioration in well-being. The faster the patient gets to a medical facility, the less contact they will have to infect.

This is a simple and inexpensive solution - a medical mask with a biomarker. The principle of action is the response of a biomarker to a change in the composition of expired gases. The color of the biomarker changes from yellow to brown as a function of the degree of change in the composition of exhaled gases.

As an ancillary tool, it is suggested to use a mobile application that will say the user if it is necessary to contact a medical facility.

What does the use of these biomarkers bring to the consumer? The consumer will be able to detect an infection at an early stage, begin treatment before complications occur and avoid mass contamination of their contacts.

What does the use of these biomarkers bring to consumer health care? The drugs may help patients at an earlier stage of infection and will help to avoid treatment of complications caused by this infection. The use of emergency and life support equipment will be reduced.

At the same time, it should be noted that this biomarker is not a test for the presence of infection, it only signals the patient about changes in the composition of exhaled gases and the possible presence of infection, which means that there is a need to undergo a medical examination for infections in the respiratory tract.

Founders of the project

Tashmatov Olim – marketing, idea development.

Tashmatov Ziyodulla – medicine, research on scientific developments, chemical, biological analytics.

Tashmatov Asadulla – software, application development.

Contacts